Publications by authors named "Abdelaziz O Surkhi"
Objectives: A multicentre European randomized control trial - European Uncomplicated Type B Aortic Repair (EU-TBAR) is being developed to compare pre-emptive TEVAR with custom-made devices vs conventional OMT. The pre-trial set-up is confluent on different pillars, including evaluation of 1) European activity, trends, and governance, 2) outcome reporting, and 3) cost evaluation. This article aimed to demonstrate the observational cross-sectional survey results from participating centres and highlight the risk assessment, activity, practices, and governance of uncomplicated type B aortic dissection (uTBAD).
View Article and Find Full Text PDFArticle Synopsis
- * A systematic review analyzed 27 studies involving 1,498 BTAI patients treated with TEVAR, finding an overall mortality rate of 12% and long-term survival rates of around 90% at 1 year post-treatment.
- * The findings suggest that while BTAI carries significant risks, TEVAR offers a safe and effective management option with a low likelihood of needing additional procedures, emphasizing the importance of timely diagnosis and transfer to trauma centers.
Article Synopsis
- - Thoracic endovascular aortic repair (TEVAR) has improved the treatment for type B aortic dissections (TBADs), but covering the left subclavian artery is crucial for effective outcomes, necessitating an additional procedure called aortic arch debranching.
- - A study analyzed 58 TBAD patients who underwent TEVAR from 2005 to 2021, revealing that nearly half had complicated conditions, with the left subclavian artery bypass performed in 26% of cases, and highlighting a notable risk of stroke.
- - The findings showed a 17.2% reintervention rate and a 29.3% mortality rate, indicating that while TEVAR and aortic arch debranching can
Article Synopsis
- - Endovascular aortic repair (EVAR) is the leading treatment for abdominal aortic aneurysms (AAA), focusing on sealing the aneurysmal sac to achieve sac regression, which is important for patient outcomes.
- - Key factors that positively affect sac regression include female sex, larger sac sizes, higher fibrinogen levels, and low intra-aneurysmal pressure, while renal impairment and ischemic heart disease tend to have negative effects.
- - Newer generation EVAR devices, particularly the Fenestrated Anaconda, show the most promising results in promoting sac regression, underscoring the importance of considering both patient conditions and device choices for optimal AAA treatment outcomes.
Background: The introduction of endovascular aortic arch repair (EAR) represents a paradigm shift in the management of complex arch pathologies usually treated with open surgical repair (OSR). This shift in treatment of aortic arch disease has also been accompanied with a rise in commercial interest in EAR resulting in the development of several endografts. However, the RELAY™ Branched by Terumo Aortic can be considered the prime endograft choice.
View Article and Find Full Text PDFPatient longevity and survival with custom-made endovascular solutions: The Fenestrated Anaconda approach.
Asian Cardiovasc Thorac Ann
September 2023
Article Synopsis
- Endovascular aortic repair (EVAR) is a key treatment for abdominal aortic aneurysms with good outcomes, but the Terumo Aortic Fenestrated Anaconda™ has shown particularly impressive results in minimizing complications and enhancing survival rates.
- A 9-year international study analyzed over 5,000 patients implanted with the Fenestrated Anaconda™, confirming 100% survival and target vessel patency in the first 6 years, though rates dropped after that.
- The study concluded that the Fenestrated Anaconda™ demonstrates exceptional effectiveness as an EVAR device, with very low instances of endograft migration or need for reintervention.
Can the Fenestrated Anaconda™ salvage failed competitor endografts? An international frame of reference.
Asian Cardiovasc Thorac Ann
September 2023
Article Synopsis
- - An abdominal aortic aneurysm (AAA) can be treated with either open surgery or endovascular aortic repair (EVAR), with EVAR considered the more effective option, particularly using fenestrated devices like the Fenestrated Anaconda from Terumo Aortic, which shows superior results.
- - A 9-year international study analyzed the performance of the custom-made Fenestrated Anaconda device, focusing on its use as a 'rescue' option for failed competitor devices, highlighting its effectiveness and versatility in complex cases.
- - Out of over 5000 EVAR procedures using the device, nearly 60% were rescue interventions, primarily due to complex anatomical issues, showing that the Fenestrated Anaconda successfully
Background: Advances in surgery over the last few decades has led to the development and widespread utilization of thoracic endovascular aortic repair (TEVAR). TEVAR, due to its minimally invasive nature and potential superior outcomes, is now becoming a key focus of interest in treating pathologies of the aortic arch, which has traditionally been treated with open surgical repair. We present our findings of our international multicentre dataset documenting the efficacy of the single-branched RELAY™ endograft in terms of technical success, postoperative outcomes, and reintervention rates.
View Article and Find Full Text PDFIntroduction: Since the introduction of endovascular aortic repair (EVAR) it has become the mainstay treatment for abdominal aortic aneurysms. Several EVAR devices exist commercially, yet, the Terumo Aortic Fenestrated Anaconda™ endograft has demonstrated outstanding results. Evidence in the literature suggests that sac regression could be linked to patient survival and longevity.
View Article and Find Full Text PDF